生物标志物
多路复用
唾液
计算机科学
冲程(发动机)
纳米光子学
生物
医学
计算生物学
化学
作者
Jiayu Liu,Yuxin Wang,Shichao Su,Meng Su,Yanlin Song,Zhao Gao,Peng Wang,Baorui Guo,R J Zhang,Renke He,Zhiyong Yin,Zeying Zhang,Meijing Liu,Junhua Zhang
标识
DOI:10.1021/acsabm.6c00103
摘要
Background: Rapid and accurate identification of stroke subtype is critical for timely intervention, yet current diagnostic assays are limited by long turnaround times, dependency on centralized laboratories, and insufficient sensitivity in the ultra-early stage. Methods: We developed a nanophotonic heterochain biosensing platform integrated with deep learning−assisted image analysis for multiplex detection of S100B, GFAP, and UCH-L1 in serum, urine, and saliva. The system consists of antibody-functionalized PS@Se heterochain biosensor, portable smartphone-based imaging, and a cloud-enabled analysis pipeline. Analytical validation was performed using recombinant protein standards, followed by clinical evaluation in ischemic stroke, intracerebral hemorrhage, and healthy controls. Results: The biosensor achieved picogram-level sensitivity with strong linearity (overall R 2 = 0.9583), high recovery (104.7%), and acceptable reproducibility (CV = 24.4%). Clinical validation demonstrated significant elevations of biomarkers in patient groups compared to controls, with distinct profiles between ischemic and hemorrhagic stroke. Integration of biomarker panels using logistic regression improved diagnostic performance over individual assays, enabling accurate discrimination of stroke subtypes within a clinically actionable window. Conclusion: This portable, AI-integrated biosensing system enables ultra-early, multiplexed, and quantitative detection of brain injury biomarkers, with potential to transform point-of-care stroke diagnostics in both clinical and field settings.
科研通智能强力驱动
Strongly Powered by AbleSci AI